Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
NESUPARIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NESUPARIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTA-NOC
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DOTA-NOC
×
Maximum Phase:
2
First Approval:
None
UNII:
1IIY9GZY9U
Molecule Type:
Small molecule
Molecular Formula:
C69H94N14O17S2
Molecular Weight:
1455.73
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LANRAPLENIB
(2)
Small molecule
Tyrosine-protein kinase SYK inhibitor
Unknown
Investigational
Unknown
LANRAPLENIB
×
Maximum Phase:
2
First Approval:
None
UNII:
A6U64OU57E
Molecule Type:
Small molecule
Molecular Formula:
C23H25N9O
Molecular Weight:
443.52
AlogP:
2.03
PSA:
109.73
HBD:
2.0
HBA:
#RotB:
5.0
Source:
LONAPRISAN
(2)
Small molecule
Progesterone receptor antagonist
Unknown
Investigational
Unknown
LONAPRISAN
×
Maximum Phase:
2
First Approval:
None
UNII:
F5Z5EL4D26
Molecule Type:
Small molecule
Molecular Formula:
C28H29F5O3
Molecular Weight:
508.53
AlogP:
6.72
PSA:
54.37
HBD:
1.0
HBA:
#RotB:
3.0
Source:
IBUTAMOREN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IBUTAMOREN
×
Maximum Phase:
2
First Approval:
None
UNII:
GJ0EGN38UL
Molecule Type:
Small molecule
Molecular Formula:
C27H36N4O5S
Molecular Weight:
528.68
AlogP:
1.77
PSA:
122.04
HBD:
2.0
HBA:
#RotB:
8.0
Source:
ABT-925
(2)
Small molecule
Dopamine D3 receptor antagonist
Unknown
Investigational
Unknown
ABT-925
×
Maximum Phase:
2
First Approval:
None
UNII:
XXV4WFG08S
Molecule Type:
Small molecule
Molecular Formula:
C20H27F3N6OS
Molecular Weight:
456.54
AlogP:
3.59
PSA:
78.27
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CARVACROL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CARVACROL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-04634817
(2)
Small molecule
C-C chemokine receptor type 2 antagonist
Unknown
Investigational
Unknown
PF-04634817
×
Maximum Phase:
2
First Approval:
None
UNII:
51M3FB9B9E
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PIREPEMAT
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PIREPEMAT
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PD-217014
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PD-217014
×
Maximum Phase:
2
First Approval:
None
UNII:
K2T93E812G
Molecule Type:
Small molecule
Molecular Formula:
C11H19NO2
Molecular Weight:
197.28
AlogP:
1.31
PSA:
52.32
HBD:
1.0
HBA:
#RotB:
3.0
Source:
VALATEGRAST
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VALATEGRAST
×
Maximum Phase:
2
First Approval:
None
UNII:
06DM4KX7JG
Molecule Type:
Small molecule
Molecular Formula:
C30H32Cl3N3O4
Molecular Weight:
604.96
AlogP:
6.43
PSA:
87.74
HBD:
2.0
HBA:
#RotB:
12.0
Source:
EVATANEPAG
(2)
Small molecule
Prostanoid EP2 receptor agonist
Unknown
Investigational
Unknown
EVATANEPAG
×
Maximum Phase:
2
First Approval:
None
UNII:
L266R6E31E
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O5S
Molecular Weight:
468.58
AlogP:
4.23
PSA:
96.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
CAMONSERTIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CAMONSERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEFERITAZOLE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DEFERITAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
4D8DC53Y1L
Molecule Type:
Small molecule
Molecular Formula:
C18H25NO7S
Molecular Weight:
399.47
AlogP:
1.79
PSA:
106.81
HBD:
2.0
HBA:
#RotB:
12.0
Source:
DECERNOTINIB
(2)
Small molecule
Tyrosine-protein kinase JAK3 inhibitor
Unknown
Investigational
Unknown
DECERNOTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
MZK2GP0RHK
Molecule Type:
Small molecule
Molecular Formula:
C18H19F3N6O
Molecular Weight:
392.39
AlogP:
3.28
PSA:
95.59
HBD:
3.0
HBA:
#RotB:
6.0
Source:
CE-326597
(2)
Small molecule
Cholecystokinin A receptor agonist
Unknown
Investigational
Unknown
CE-326597
×
Maximum Phase:
2
First Approval:
None
UNII:
1FGZ6L9SF2
Molecule Type:
Small molecule
Molecular Formula:
C37H34N6O2
Molecular Weight:
594.72
AlogP:
6.53
PSA:
87.12
HBD:
1.0
HBA:
#RotB:
8.0
Source:
PARTHENOLIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PARTHENOLIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
2RDB26I5ZB
Molecule Type:
Small molecule
Molecular Formula:
C15H20O3
Molecular Weight:
248.32
AlogP:
2.76
PSA:
38.83
HBD:
0.0
HBA:
#RotB:
0.0
Source:
IBIPINABANT
(2)
Small molecule
Cannabinoid CB1 receptor antagonist
Unknown
Investigational
Unknown
IBIPINABANT
×
Maximum Phase:
2
First Approval:
None
UNII:
O5CSC6WH1T
Molecule Type:
Small molecule
Molecular Formula:
C23H20Cl2N4O2S
Molecular Weight:
487.41
AlogP:
4.76
PSA:
74.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
XANTHOHUMOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
XANTHOHUMOL
×
Maximum Phase:
2
First Approval:
None
UNII:
T4467YT1NT
Molecule Type:
Small molecule
Molecular Formula:
C21H22O5
Molecular Weight:
354.4
AlogP:
4.22
PSA:
86.99
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ONO-2333MS
(2)
Small molecule
Corticotropin releasing factor receptor 1 antagonist
Unknown
Investigational
Unknown
ONO-2333MS
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
YM-543
(2)
Small molecule
Sodium/glucose cotransporter 2 inhibitor
Unknown
Investigational
Unknown
YM-543
×
Maximum Phase:
2
First Approval:
None
UNII:
KA83KI0EO9
Molecule Type:
Small molecule
Molecular Formula:
C28H37NO7
Molecular Weight:
499.6
AlogP:
1.6
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
4.0
Source:
AVADOMIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
AVADOMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
28DZS29F59
Molecule Type:
Small molecule
Molecular Formula:
C14H14N4O3
Molecular Weight:
286.29
AlogP:
0.26
PSA:
107.08
HBD:
2.0
HBA:
#RotB:
1.0
Source:
EMIVIRINE
(2)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
Unknown
Investigational
Unknown
EMIVIRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
X87G8IX72O
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O3
Molecular Weight:
302.37
AlogP:
2.24
PSA:
64.09
HBD:
1.0
HBA:
#RotB:
6.0
Source:
METHYLINOSITOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
METHYLINOSITOL
×
Maximum Phase:
2
First Approval:
None
UNII:
TF9HZN9T0M
Molecule Type:
Small molecule
Molecular Formula:
C7H14O6
Molecular Weight:
194.18
AlogP:
-3.18
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
INDISULAM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
INDISULAM
×
Maximum Phase:
2
First Approval:
None
UNII:
WJ98J3NM90
Molecule Type:
Small molecule
Molecular Formula:
C14H12ClN3O4S2
Molecular Weight:
385.85
AlogP:
2.27
PSA:
122.12
HBD:
3.0
HBA:
#RotB:
4.0
Source:
GOSSYPOL ACETIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
GOSSYPOL ACETIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
S7RL72610R
Molecule Type:
Small molecule
Molecular Formula:
C42H42O14
Molecular Weight:
770.78
AlogP:
7.7
PSA:
191.94
HBD:
0.0
HBA:
#RotB:
11.0
Source:
LUTEOLIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LUTEOLIN
×
Maximum Phase:
2
First Approval:
None
UNII:
KUX1ZNC9J2
Molecule Type:
Small molecule
Molecular Formula:
C15H10O6
Molecular Weight:
286.24
AlogP:
2.28
PSA:
111.13
HBD:
4.0
HBA:
#RotB:
1.0
Source:
VENGLUSTAT MALATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VENGLUSTAT MALATE
×
Maximum Phase:
2
First Approval:
None
UNII:
94855LQZ8D
Molecule Type:
Small molecule
Molecular Formula:
C24H30FN3O7S
Molecular Weight:
523.58
AlogP:
4.0
PSA:
54.46
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GSK-2269557
(2)
Small molecule
PI3-kinase p110-delta subunit inhibitor
Unknown
Investigational
Unknown
GSK-2269557
×
Maximum Phase:
2
First Approval:
None
UNII:
II4WQU7U3O
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLCEGEPANT
(2)
Small molecule
Calcitonin gene-related peptide type 1 receptor antagonist
Unknown
Investigational
Unknown
OLCEGEPANT
×
Maximum Phase:
2
First Approval:
None
UNII:
WOA5J8TX6M
Molecule Type:
Small molecule
Molecular Formula:
C38H47Br2N9O5
Molecular Weight:
869.66
AlogP:
4.41
PSA:
176.47
HBD:
5.0
HBA:
#RotB:
12.0
Source:
CAMPTOTHECIN-20-O-PROPIONATE
(2)
Small molecule
DNA topoisomerase I inhibitor
Unknown
Investigational
Unknown
CAMPTOTHECIN-20-O-PROPIONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4S145C552U
Molecule Type:
Small molecule
Molecular Formula:
C23H20N2O5
Molecular Weight:
404.42
AlogP:
3.04
PSA:
87.49
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SARCOSINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SARCOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Z711V88R5F
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO2
Molecular Weight:
89.09
AlogP:
-0.71
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IOWH-032
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
IOWH-032
×
Maximum Phase:
2
First Approval:
None
UNII:
8Y3GDT6YWV
Molecule Type:
Small molecule
Molecular Formula:
C22H15Br2N3O4
Molecular Weight:
545.19
AlogP:
5.69
PSA:
97.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NERINDOCIANINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
NERINDOCIANINE
×
Maximum Phase:
2
First Approval:
None
UNII:
1GZ5G85KVT
Molecule Type:
Small molecule
Molecular Formula:
C44H52N2O16S5
Molecular Weight:
1025.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TNP-2092
(2)
Small molecule
Bacterial DNA gyrase inhibitor
Unknown
Investigational
Unknown
TNP-2092
×
Maximum Phase:
2
First Approval:
None
UNII:
W2P7EF7O6O
Molecule Type:
Small molecule
Molecular Formula:
C65H81FN6O15
Molecular Weight:
1205.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PCI-27483
(2)
Small molecule
Coagulation factor VII inhibitor
Unknown
Investigational
Unknown
PCI-27483
×
Maximum Phase:
2
First Approval:
None
UNII:
6073LCU8U9
Molecule Type:
Small molecule
Molecular Formula:
C26H24N6O9S
Molecular Weight:
596.58
AlogP:
0.83
PSA:
282.87
HBD:
9.0
HBA:
#RotB:
10.0
Source:
1
2
…
128
129
130
131
132
133
134
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA